Hypoxia induces HIF-1α and VEGF expression in chondrosarcoma cells and chondrocytes

被引:169
作者
Lin, CZ
McGough, R
Aswad, B
Block, JA
Terek, R
机构
[1] Brown Univ, Sch Med, Rhode Isl Hosp, Dept Orthopaed, Providence, RI 02912 USA
[2] Rhode Isl Hosp, Brown Sch Med, Dept Pathol, Providence, RI USA
[3] Rush Presbyterian St Lukes Med Ctr, Rheumatol Sect, Chicago, IL USA
关键词
angiogenesis; hypoxia; chondrosarcoma; cartilage metabolism;
D O I
10.1016/j.orthres.2004.03.002
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Like other tumors, chondrosarcoma must induce neovascularity as they grow. Recent studies have demonstrated that chondrosarcoma are vascular. Since normal cartilage is a hypoxic, yet avascular tissue and since chondrosarcoma bears some phenotypic relation to cartilage, it is not clear if hypoxic pathways remain intact in these tissues. Hypoxia-inducible factor 1alpha (HIF-1alpha) is the inducible subunit of the HIF-1 transcription factor that regulates genes involved in the response to hypoxia, some of which promote neovascularity. Vascular endothelial growth factor (VEGF) is one of the genes upregulated by HIF-1 and is the primary cytokine related to angiogenesis. In this study we examined the response of chondrocytes and chondrosarcoma cell lines to hypoxia. We found that both normal and malignant chondrocytes increased HIF-1alpha protein expression in an oxygen concentration dependent manner and also increased VEGF mRNA expression in response to hypoxia. HIF-1alpha protein and VEGF mRNA decreased when chondrosarcoma cells were transfected with siRNA targeting HIF-1alpha prior to hypoxia exposure, suggesting that HIF-1alpha expression resulted in increased VEGF expression. The role of the HIF-1alpha/VEGF pathway in angiogenesis in chondrosarcoma in vivo and its usefulness as a target for antiangiogenic treatment strategies for this tumor requires further investigation. (C) 2004 Orthopaedic Research Society. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:1175 / 1181
页数:7
相关论文
共 34 条
[11]   Specific loss of chondromodulin-I gene expression in chondrosarcoma and the suppression of tumor angiogenesis and growth by its recombinant protein in vivo [J].
Hayami, T ;
Shukunami, C ;
Mitsui, K ;
Endo, N ;
Tokunaga, K ;
Kondo, J ;
Takahashi, HE ;
Hiraki, Y .
FEBS LETTERS, 1999, 458 (03) :436-440
[12]   Molecular cloning of human chondromodulin-I, a cartilage-derived growth modulating factor, and its expression in Chinese hamster ovary cells [J].
Hiraki, Y ;
Mitsui, K ;
Endo, N ;
Takahashi, K ;
Hayami, T ;
Inoue, H ;
Shukunami, C ;
Tokunaga, K ;
Kono, T ;
Yamada, M ;
Takahashi, HE ;
Kondo, J .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1999, 260 (03) :869-878
[13]   Chondromodulin-I as a novel cartilage-specific growth-modulating factor [J].
Hiraki, Y ;
Shukunami, C .
PEDIATRIC NEPHROLOGY, 2000, 14 (07) :602-605
[14]   The von Hippel-Lindau gene, kidney cancer, and oxygen sensing [J].
Kaelin, WG .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (11) :2703-2711
[15]  
Krishnamachary B, 2003, CANCER RES, V63, P1138
[16]   Cancer/testis antigen CSAGE is concurrently expressed with MAGE in chondrosarcoma [J].
Lin, CZ ;
Mak, S ;
Meitner, PA ;
Wolf, JM ;
Bluman, EM ;
Block, JA ;
Terek, RM .
GENE, 2002, 285 (1-2) :269-278
[17]   Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method [J].
Livak, KJ ;
Schmittgen, TD .
METHODS, 2001, 25 (04) :402-408
[18]   Activation of the HIF pathway in cancer [J].
Maxwell, PH ;
Pugh, CW ;
Ratcliffe, PJ .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2001, 11 (03) :293-299
[19]  
MCGOUGH R, 2002, CLIN ORTH REL RES
[20]  
Morioka H, 2003, CLIN CANCER RES, V9, P1211